NCT00913081View on ClinicalTrials.gov

Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH)

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

December 31, 2009

Conditions
Flushing
Interventions
DIETARY_SUPPLEMENT

Quercetin

Quercetin 500, 1000, or 2000 mg PO one time

DIETARY_SUPPLEMENT

Placebo

Placebo PO one time

Trial Locations (2)

19104

CTRC Univ. of Penn - Andrew Mutch Bldg., 4th floor, Philadelphia

University of Pennsylvania, Philadelphia

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

University of Pennsylvania

OTHER